These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6994781

  • 61. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I, Skultétyová D, Mikulecký M, Kratochvíl'ová H.
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [Abstract] [Full Text] [Related]

  • 62. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
    Keenan RE, Black PL, Freudenburg JC, Hill JA, Holmburg CE, Reitbrock MJ, Sullivan MJ, Thompson MT, Wright DL.
    Am J Cardiol; 1986 Mar 28; 57(9):38E-42E. PubMed ID: 3513529
    [Abstract] [Full Text] [Related]

  • 63. [Antihypertensive treatment with guanfacine in patients with type II diabetes mellitus].
    Coves MJ, Gomis R, Goday A, Casamitjana R, Rivera F, Vilardell E.
    Med Clin (Barc); 1987 Feb 28; 88(8):315-7. PubMed ID: 3550310
    [No Abstract] [Full Text] [Related]

  • 64. A new centrally action antihypertensive agent guanfacine (BS 100-141).
    Dubach UC, Huwyler R, Radielovic P, Singeisen M.
    Arzneimittelforschung; 1977 Feb 28; 27(3):674-6. PubMed ID: 326262
    [Abstract] [Full Text] [Related]

  • 65. A symposium: Guanfacine--a new choice in centrally acting antihypertensive agents. October 5-6, 1984, Scottsdale, Arizona.
    Am J Cardiol; 1986 Mar 28; 57(9):1E-61E. PubMed ID: 3513524
    [No Abstract] [Full Text] [Related]

  • 66. [Evaluation of the hypotensive effect of guanfacine].
    Adamska-Dyniewska H, Dziekański S.
    Pol Arch Med Wewn; 1988 Jun 28; 79(6):289-95. PubMed ID: 3078198
    [No Abstract] [Full Text] [Related]

  • 67. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M, Canto J, Yapur H, Oller JM.
    Rev Clin Esp; 1988 Jun 28; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract] [Full Text] [Related]

  • 68. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Bazika V, Neuzil P, Tiserová J, Hrabovský F.
    Cas Lek Cesk; 1986 May 23; 125(21):637-40. PubMed ID: 3518943
    [No Abstract] [Full Text] [Related]

  • 69. Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year.
    Hauger-Klevene JH, Scornavacchi JC.
    Eur J Clin Pharmacol; 1985 May 23; 29(4):391-3. PubMed ID: 3912183
    [Abstract] [Full Text] [Related]

  • 70. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I, Podrouzková B, Kocourková J, Kubesová H, Spác J, Nĕmcová H, Blaha M.
    Cor Vasa; 1987 May 23; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [Abstract] [Full Text] [Related]

  • 71. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
    Materson BJ, Kessler WB, Alderman MH, Canosa FL, Finnerty FA, Savran SV, McMillen JI, Marlon AM.
    Am J Cardiol; 1986 Mar 28; 57(9):32E-37E. PubMed ID: 3513528
    [Abstract] [Full Text] [Related]

  • 72. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J, Schäfer N, Rauh J, Raschig A.
    Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524
    [Abstract] [Full Text] [Related]

  • 73. Long-term evaluations of therapeutic efficacy and safety of guanfacine.
    Jerie P.
    Am J Cardiol; 1986 Mar 28; 57(9):55E-59E. PubMed ID: 3513532
    [Abstract] [Full Text] [Related]

  • 74. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV, Beliakova EV, Charyev KhZ, Panfilov VV.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989 Mar 28; 12(1):63-7. PubMed ID: 2663029
    [Abstract] [Full Text] [Related]

  • 75. Concentration-dependent blood pressure effects of guanfacine.
    Frisk-Holmberg M, Wibell L.
    Clin Pharmacol Ther; 1986 Feb 28; 39(2):169-72. PubMed ID: 2867846
    [Abstract] [Full Text] [Related]

  • 76. [Clinical trial of a new antihypertensive preparation: guanfacine].
    Rengo F, Ricciardelli B, Spirito G, Volpe M, Morrone G, Trimarco B, Condorelli M.
    Boll Soc Ital Cardiol; 1979 Feb 28; 24(10):1097-102. PubMed ID: 400394
    [No Abstract] [Full Text] [Related]

  • 77. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J, Jäger H.
    MMW Munch Med Wochenschr; 1980 Jan 25; 122(4):137-40. PubMed ID: 6767938
    [Abstract] [Full Text] [Related]

  • 78. Antihypertensive treatment in mild hypertension, its problems and future trends.
    Widimský J.
    Cor Vasa; 1987 Jan 25; 29(4 Suppl 1):1-10. PubMed ID: 3315445
    [No Abstract] [Full Text] [Related]

  • 79. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME, Loria Y, Weiss YA, Boutier JR.
    J Clin Pharmacol; 1982 Jan 25; 22(8-9):385-90. PubMed ID: 6752213
    [Abstract] [Full Text] [Related]

  • 80. Long-term antihypertensive therapy with guanfacine.
    Szám I, Holló J.
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug 25; 20(8):388-92. PubMed ID: 6749702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.